NVST

NYSE Healthcare

Envista Holdings Corporation Common Stock

Medical Instruments & Supplies

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

๐Ÿ“Š Market Data
Price$26.33
Volume1,671,562
Market Cap4.29B
Beta0.980
RSI (14-Day)43.1
200-Day MA$22.87
50-Day MA$26.74
52-Week High$30.42
52-Week Low$16.29
P/E Ratio94.04
Forward P/E16.89
Price / Book1.39
๐ŸŽฏ Investment Strategy Scores

NVST scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 35/100โ–ฒ +1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 69/100โ–ฒ +1
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 53/100โ–ผ -3
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 20/100โ–ฒ +1
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿš€ Moon Shot (69/100) โ€” this strategy High growth potential (high beta + oversold).

Lowest fit among scored strategies: ๐ŸŽˆ Over-Hyped (20/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find NVST in your text

Paste any article, transcript, or post โ€” the tool will extract NVST and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.